Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Clin Case Rep ; 10(2): e05406, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-35145691

RESUMEN

We report a case of new-onset type 1 diabetes in a girl presenting with severe diabetic ketoacidosis, complicated by profound hypokalemia and hypernatremia. We describe the clinical course, management challenges, and the potential role of the concomitant COVID-19 infection in the complexity of this case.

2.
Arch Dis Child Fetal Neonatal Ed ; 92(5): F347-50, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17012305

RESUMEN

OBJECTIVE: To determine whether the effects of sleeping position on lung volume and oxygenation are influenced by postmenstrual age (PMA) and oxygen dependency in convalescent prematurely born infants. DESIGN: Prospective study. SETTING: Tertiary neonatal unit. PATIENTS: 41 infants (21 oxygen dependent), median gestational age 28 weeks (range 24-31 weeks) and birth weight 1120 g (range 556-1780 g). INTERVENTION: Infants were studied both supine and prone at two-weekly intervals from 32 weeks' PMA until discharge. Each posture was maintained for 1 h. MAIN OUTCOME MEASURES: Pulse oximeter oxygen saturation (Spo(2)) was monitored continuously, and at the end of each hourly period functional residual capacity (FRC) was measured. RESULTS: Overall, lung volumes were higher in the prone position throughout the study period; there was no significant effect of PMA on lung volumes. Overall, Spo(2) was higher in the prone position (p = 0.02), and the effect was significant in the oxygen-dependent infants (p = 0.03) (mean difference in Spo(2) between prone and supine was 1.02%, 95% CI 0.11% to 1.92%), but not in the non-oxygen-dependent infants. There was no significant influence of PMA on Spo(2). CONCLUSION: In the present study, prone sleeping did not improve oxygenation in prematurely born infants, 32 weeks' PMA or older and with no ongoing respiratory problems. However, the infants were monitored in each position for an hour, thus it is recommended that oxygen saturation should continue to be monitored after 32 weeks' PMA to be certain that longer periods of supine sleeping are not associated with loss of lung volume and hypoxaemia.


Asunto(s)
Recien Nacido Prematuro/fisiología , Pulmón/fisiología , Oxígeno/fisiología , Postura/fisiología , Sueño/fisiología , Capacidad Residual Funcional/fisiología , Edad Gestacional , Humanos , Recién Nacido , Oximetría/métodos , Terapia por Inhalación de Oxígeno/métodos , Posición Prona/fisiología , Estudios Prospectivos , Posición Supina/fisiología
3.
Paediatr Respir Rev ; 6(2): 111-6, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15911456

RESUMEN

Pulmonary hypertension of the newborn occurs in 1.9 per 1000 live births and affected infants are hypoxaemic because of right-to-left shunts through the ductus arteriosus and foramen ovale. Pulmonary hypertension of the newborn may be primary, or secondary to a variety of conditions including intrapartum asphyxia, infection, pulmonary hypoplasia, congenital heart disease or drug therapy. It may occur in association with a normal number (maladaptation) or a decreased number of arteries (for example with pulmonary hypoplasia). Few strategies used in infants with pulmonary hypertension of the newborn have been subjected to rigorous evaluation. Inhaled nitric oxide has been shown to reduce the need for extracorporeal membrane oxygenation but not mortality, in term or near term born infants. Preliminary evidence suggests that other vasodilators given by the inhaled route may improve oxygenation and new vasodilators have become available; appropriately designed trials with long-term outcomes are required to test such therapies.


Asunto(s)
Hipertensión Pulmonar/diagnóstico , Hipertensión Pulmonar/terapia , Bloqueadores de los Canales de Calcio/uso terapéutico , Epoprostenol/uso terapéutico , Oxigenación por Membrana Extracorpórea , Humanos , Hipertensión Pulmonar/mortalidad , Hiperventilación , Lactante , Recién Nacido , Óxido Nítrico/uso terapéutico , Inhibidores de Fosfodiesterasa/uso terapéutico , Tasa de Supervivencia , Tolazolina/uso terapéutico , Vasodilatadores/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...